Skip to main content
. Author manuscript; available in PMC: 2019 Sep 5.
Published in final edited form as: Biochem Biophys Res Commun. 2018 Jun 23;503(2):856–862. doi: 10.1016/j.bbrc.2018.06.087

Fig. 4.

Fig. 4.

IGF1R has 3’UTR shortening in NSCLC samples. The transcript expression levels of IGF1R were determined using RNA-seq data from the Cancer Genome Altas in lung adenocarcinoma (LUAD) (A) and lung squamous cell carcinoma (LUSC) (B) compared to matched controls. The PDUI of IGF1R were calculated in LUAD (C) and LUSC (D) and compared to their controls to determine the usage of distal PAS.